Evaluation of Analgesic effect of intravenous lidocaine versus intravenous morphine sulfate in pain reduction in long or short bones fractures of upper and lower limbs

Phase 3

Conditions: Condition 1: Fracture. Condition 2: farcture. Condition 3: fracture. Condition 4: Fracture. Condition 5: fracture. Condition 6: fracture. Condition 7: fracture.
Fracture at wrist and hand level
Fracture of shoulder and upper arm
Fracture of femur
Fracture of forearm
Other fractures of long or short bones
Fracture of lower leg, including ankle
Fracture of foot, except ankle
S00-T98

Registration Number: IRCT2015052622423N1

Lead Sponsor: Vice chancellor for research Ahvaz Jundishapoor Univercity of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Complete

Sex: All

Target Recruitment: 280

Inclusion Criteria

Inclusion criteris : All patients 15-65 years of age with long or short upper or lower bone fracture, referring to emergency ward of Imam Khomeini and Golestan hospital in Ahwaz city.
Exclusion criterias: Persons under 15 years; People over 65 years; Pregnant and lactating women; People with loss of consciousness; Hemodynamic disorder ; Traumatic patients with evidence of intra abdominal or intra pelvic hemorrhage ; mental retard patients; History of allergy to lidocaine or morphine; People treated with NA; People with underlying disease (Coronary artery disease ; Diabetes; Heart valvular disease; history of Cardiac arrhythmia; Hypertention; Cerebrovascular disease; seizure; history of liver or renal disease); history of heart drugs; history of addiction

Exclusion Criteria

Not provided

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pain. Timepoint: 0-5-10-15-20-25-30-minute. Method of measurement: vas score.

Secondary Outcome Measures

Name	Time	Method
Blood pressure. Timepoint: 0-10-15-20-25-30 minute. Method of measurement: with manometer.;Pulse rate. Timepoint: 0-10-15-20-25-30 minute. Method of measurement: Count per minute.;Spo2. Timepoint: 0-10-15-20-25-30 minute. Method of measurement: with pulse oximetry.;Respiratory rate. Timepoint: 0-10-15-20-25-30 minute. Method of measurement: Count per minute.